Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessing Response to Therapy in Neuroblastoma with MRI T1 Mapping.

Literature DB >> 33778740

Assessing Response to Therapy in Neuroblastoma with MRI T1 Mapping.

Gary D Luker.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2020 PMID： 33778740 PMCID： PMC7983719 DOI： 10.1148/rycan.2020209026

Source DB: PubMed Journal: Radiol Imaging Cancer ISSN： 2638-616X

Keyword Cloud
References

× No keyword cloud information.

1 in total

1. Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma.

Authors: Konstantinos Zormpas-Petridis; Evon Poon; Matthew Clarke; Neil P Jerome; Jessica K R Boult; Matthew D Blackledge; Fernando Carceller; Alexander Koers; Giuseppe Barone; Andrew D J Pearson; Lucas Moreno; John Anderson; Neil Sebire; Kieran McHugh; Dow-Mu Koh; Louis Chesler; Yinyin Yuan; Simon P Robinson; Yann Jamin
Journal: Cancer Res Date: 2020-06-28 Impact factor: 12.701

1 in total

Assessing Response to Therapy in Neuroblastoma with MRI T1 Mapping.

1. Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma.

1. Noninvasive MRI Native T₁ Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma.